Paley M N, Chong W K, Wilkinson I D, Shepherd J K, Clews A M, Sweeney B J, Hall-Craggs M A, Kendall B E, Newman S P, Harrison M J
Department of Neurology, University College London Medical School and Middlesex Hospital, England.
Radiology. 1994 Mar;190(3):879-86. doi: 10.1148/radiology.190.3.8115644.
To prospectively study the cerebrospinal fluid volume-total intracranial volume ratio (CSF/ICV) in human immunodeficiency virus (HIV)-infected patients at various stages of disease.
A total of 258 volume measurements were obtained with use of a 1.5-T magnetic resonance (MR) imager and the cluster localized automated spherical segmentation technique (which reduces two-dimensional pixel data from dual spin-echo MR images to a one-dimensional histogram) in 69 control subjects and 189 HIV-infected patients.
The CSF/ICV was statistically significantly increased in patients with late-stage (Centers for Disease Control and Prevention group IV) acquired immunodeficiency syndrome (AIDS) (0.16 +/- 0.05 [standard deviation]) compared with seronegative control subjects (0.12 +/- 0.03) and patients without symptoms (0.13 +/- 0.03).
No substantial change in CSF/ICV occurs until development of late-stage AIDS.
前瞻性研究处于疾病不同阶段的人类免疫缺陷病毒(HIV)感染患者的脑脊液体积与总颅内体积之比(CSF/ICV)。
使用1.5-T磁共振(MR)成像仪和簇定位自动球形分割技术(该技术将双自旋回波MR图像的二维像素数据简化为一维直方图),对69名对照受试者和189名HIV感染患者进行了总共258次体积测量。
与血清阴性对照受试者(0.12±0.03)和无症状患者(0.13±0.03)相比,晚期(疾病控制和预防中心IV组)获得性免疫缺陷综合征(AIDS)患者的CSF/ICV在统计学上显著增加(0.16±0.05[标准差])。
在晚期AIDS出现之前,CSF/ICV无实质性变化。